Qube Research & Technologies (QRT)
PLXP

Qube Research & Technologies (QRT)’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,299
Closed -$62K – 3298
2022
Q1 		$62K Sell
15,299
-23,392
-60% -$128K ﹤0.01% 2155
2021
Q4 		$310K Buy
+38,691
New +$454K ﹤0.01% 1795

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PLXP Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2022, closing a stake of 15,299 shares — an estimated $62K sold.

Qube Research & Technologies (QRT) first reported a position in PLXP in Q4 2021 and held it in 2 quarters. The position peaked at $310K in Q4 2021. 48 funds tracked by Wall St. Rank hold PLXP as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 15,299 PLx Pharma Inc. Common Stock shares in Q2 2022, an estimated $62K.
  • Qube Research & Technologies (QRT) first reported a position in PLx Pharma Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s PLx Pharma Inc. Common Stock position peaked at $310K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.